Our cellular data indicated that HTPB inhibited cancer cell migration through inhibiting activity of matrix metalloproteinases, RhoA, integrin-β1 and focal adhesion complex (Fig. 3) and disrupting F-actin arrangement (Fig. 3). The gene discussed is RHOA; the disease is cancer.